Live Breaking News & Updates on Halozyme therapeutics daily

Stay updated with breaking news from Halozyme therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TD Asset Management Inc Increases Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

TD Asset Management Inc Increases Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Belgium , Japan , Switzerland , United-states , Michaelj-labarre , Td-asset-management-inc , Securities-exchange-commission , Halozyme-therapeutics-company-profile , Nasdaq , Halozyme-therapeutics-inc , Quadrant-capital-group

TD Asset Management Inc Increases Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

TD Asset Management Inc Increases Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Japan , Belgium , Switzerland , Michaelj-labarre , Harvey-capital-management-inc , Hsbc-holdings , Wafra-inc , Exchange-commission

Bernzott Capital Advisors Sells 46,829 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Bernzott Capital Advisors trimmed its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 27.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 124,979 shares of the biopharmaceutical company’s stock after selling 46,829 shares during the quarter. Bernzott Capital Advisors’ holdings in Halozyme Therapeutics were worth $4,619,000 at the end of […] ....

Japan , United-states , Belgium , Switzerland , Michaelj-labarre , Quadrant-capital-group , Holdings-channel , Parkside-financial-bank , Nasdaq , First-horizon-advisors-inc , Principal-securities-inc

Halozyme Therapeutics' (HALO) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $50.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts also recently issued research reports about the stock. TD Cowen began coverage on shares of […] ....

Boston , Massachusetts , United-states , Belgium , Japan , Switzerland , Michaelj-labarre , Halozyme-therapeutics-company-profile , Wafra-inc , Hsbc-holdings , Nasdaq

HC Wainwright Reaffirms Buy Rating for Halozyme Therapeutics (NASDAQ:HALO)

HC Wainwright restated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a research note released on Wednesday morning, Benzinga reports. They currently have a $50.00 target price on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. JMP Securities cut their target price on shares of […] ....

Boston , Massachusetts , United-states , Belgium , Switzerland , Japan , Michaelj-labarre , Hsbc-holdings , Wafra-inc , International-assets-investment-management , Securities-exchange-commission